Ranked by reported Q2 2026 13F market value
Share of total reported institutional value in FULC held by the largest 10 / 25 filers.
| # | Institution | Shares Held | Market Value | QoQ Change | Ownership % | % of Fund |
|---|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 8.8M | $32.3M | +63.7% | 16.308% | 0.00% |
| 2 | EcoR1 Capital, LLC | 6.5M | $24.0M | β | 12.104% | 1.17% |
| 3 | TANG CAPITAL MANAGEMENT LLC | 6.5M | $23.9M | β | 12.052% | 1.08% |
| 4 | Nantahala Capital Management, LLC | 5.5M | $20.0M | +79.5% | 10.118% | 0.33% |
| 5 | MONTANOVA CAPITAL, LLC | 3.7M | $13.5M | -43.9% | 6.803% | 0.25% |
| 6 | D. E. Shaw & Co., Inc. | 3.0M | $11.1M | +87.5% | 5.626% | 0.01% |
| 7 | CITADEL ADVISORS LLC | 2.9M | $10.8M | +117.8% | 5.436% | 0.00% |
| 8 | VANGUARD CAPITAL MANAGEMENT LLC | 2.7M | $9.9M | +0.2% | 4.985% | 0.00% |
| 9 | JANE STREET GROUP, LLC | 2.3M | $8.4M | +589.1% | 4.224% | 0.00% |
| 10 | STATE STREET CORP | 2.0M | $7.5M | +31.4% | 3.764% | 0.00% |
| 11 | ADAGE CAPITAL PARTNERS GP, L.L.C. | 2.0M | $7.3M | +400.0% | 3.696% | 0.01% |
| 12 | GSK plc | 1.8M | $6.5M | 0.0% | 3.300% | 1.09% |
| 13 | Qube Research & Technologies Ltd | 1.7M | $6.4M | +79.4% | 3.231% | 0.01% |
| 14 | RENAISSANCE TECHNOLOGIES LLC | 1.6M | $6.0M | +12016.2% | 3.045% | 0.01% |
| 15 | ADAR1 Capital Management, LLC | 1.6M | $5.7M | +1098.7% | 2.892% | 0.26% |
| 16 | MILLENNIUM MANAGEMENT LLC | 1.5M | $5.4M | +316.8% | 2.746% | 0.00% |
| 17 | GEODE CAPITAL MANAGEMENT, LLC | 1.4M | $5.2M | -3.7% | 2.647% | 0.00% |
| 18 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 1.4M | $5.2M | +326.3% | 2.640% | 0.00% |
| 19 | MARSHALL WACE, LLP | 1.4M | $5.0M | β | 2.510% | 0.00% |
| 20 | UBS Group AG | 1.3M | $4.6M | +297.8% | 2.317% | 0.00% |
| 21 | AQR CAPITAL MANAGEMENT LLC | 1.1M | $4.0M | +103.1% | 2.039% | 0.00% |
| 22 | GOLDMAN SACHS GROUP INC | 1.1M | $4.0M | +91.4% | 2.022% | 0.00% |
| 23 | Ikarian Capital, LLC | 1.0M | $3.8M | 0.0% | 1.939% | 0.41% |
| 24 | BANK OF AMERICA CORP /DE/ | 1.0M | $3.8M | +724.1% | 1.928% | 0.00% |
| 25 | Jump Financial, LLC | 1.0M | $3.7M | +171.8% | 1.857% | 0.03% |
denotes a marquee investor (Buffett, Burry, ARK, Tiger Global, Pershing Square, Baupost and other widely-followed managers). β% of Fundβ shows how much of that investorβs total 13F portfolio is invested in FULC β a direct measure of their conviction.
Filings activity in FULC during Q2 2026, grouped by how each filer changed its position.
8 quarters of 13F filings Β· Ξ columns show change vs prior quarter
| Quarter | Inst. Holders | Ξ Holders | Ownership % | Ξ Ownership | Total 13F Value | Ξ Value |
|---|---|---|---|---|---|---|
| Q2 2026 | 153 | 8.4% | 147.50% | 5.77 pp | $287M | 48% |
| Q1 2026 | 167 | 1.2% | 153.27% | +9.60 pp | $546M | 28% |
| Q4 2025 | 169 | +34% | 143.67% | +2.90 pp | $753M | +55% |
| Q3 2025 | 126 | +4.1% | 140.77% | 2.67 pp | $485M | +31% |
| Q2 2025 | 121 | +3.4% | 143.44% | +10.17 pp | $369M | +156% |
| Q1 2025 | 117 | 1.7% | 133.27% | 2.00 pp | $144M | 40% |
| Q4 2024 | 119 | 4.8% | 135.27% | 5.85 pp | $239M | +26% |
| Q3 2024 | 125 | β | 141.12% | β | $189M | β |
Source: SEC 13F institutional filings. Ownership % requires market cap data and will show once linked. Ξ columns compare to the immediately prior filed quarter.
Institutional ownership and quarterly buying activity across the largest Neuroscience Biotech peers.
Quick answers to the most common questions about buying FULC stock.
Based on Q2 2026 13F filings, institutional ownership of Fulcrum Therapeutics, Inc. stands at 147.5%, held across 153 reporting institutions.
BlackRock, Inc. is the largest reported institutional holder of FULC, with approximately 8,824,259 shares worth $0.03B as of Q2 2026.
Yes β 5 widely-followed marquee investors appear among the top 25 institutional holders of FULC, including CITADEL ADVISORS LLC, JANE STREET GROUP, LLC, RENAISSANCE TECHNOLOGIES LLC, MILLENNIUM MANAGEMENT LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP.
Our composite Smart Money Score for FULC is 50 out of 100 (Neutral). It combines net institutional buying activity, ownership shift, marquee investor presence, and holder-count growth.
27 institutions opened new positions in FULC during Q2 2026, while 41 fully exited. 29 added to existing positions and 96 trimmed.
FULC institutional ownership fell by 5.77 percentage points quarter-over-quarter, with a net change of -14 holders.
The top 10 institutions account for 56.3% of all reported 13F value in FULC, and the top 25 account for 83.1%.
Across the largest Neuroscience Biotech peers, institutional ownership levels are: DFTX (89.1%), HELP (49.7%), KRSA (10.0%), FLNA (28.5%). See the peer comparison table on this page for net buyer activity by company.
All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.